A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.
The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.
What Does Field Trip Psychedelics Offer Investors?
Field Trip Psychedelics has just announced a letter of intent to go public via RTO.
Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll
Canadians are rapidly warming up to the idea of using psilocybin to reduce distress among the terminally ill.
ATAI Life Sciences Forges Premier Psychedelics R&D Platform
ATAI Life Sciences is preparing to add three new drug development partners as it builds the premier R&D platform in the psychedelics space.
What A Trip! Psychedelics Stocks Flying High
Several psychedelics companies have generated impressive returns for investors in recent weeks.
Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
In a "bad" year for the emerging cannabis industry, global cannabis sales rose by 48% in 2019. That's not bad.
Is CBD ‘Harmful’ to Our Liver? No.
The U.S. Food and Drug Administration is claiming that CBD poses significant risks to the human liver. Nonsense.
Industry Leaders Leading Turnaround in Marijuana Stocks?
The largest U.S.-based cannabis company and the largest Canadian cannabis company have both seen their stock make strong moves. Will other cannabis companies follow?
The U.S. Cannabis Revolution: Two Charts
As the U.S. Cannabis Revolution unfolds, over 90% of Americans now want cannabis legalized (at least) for medical purposes. Attention Congress.
A New Era Begins For Retail Cannabis In Ontario
The new cannabis store licensing system has commenced in Ontario. Total retail cannabis stores could multiply by nearly a factor of 10 in 2020.
The Year of Opportunity: Marijuana Stocks to Watch in 2020
The 2019 meltdown in marijuana stocks is now an opportunity for value investors in 2020.
2019 Cannabis Review: How Blood In The Streets Has Created An EPIC Buying Opportunity
2019 will be remembered as a bad year for cannabis investing. But there were also several important highlights this year that could set the stage for an epic rally -- next year.
Interview With Terry Donnelly, Cannabis Beverage Producers Alliance
Cannabis-infused beverages will start appearing on store shelves in some Canadian provinces any day how. What are the expectations with these products?